Patents by Inventor Alex Smolyar

Alex Smolyar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7148050
    Abstract: Reagents that regulate human protein kinase-like protein and reagents which bind to human protein kinase-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, CNS disorders, COPD, obesity, diabetes, and cardiovascular disorders.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: December 12, 2006
    Assignee: Bayer Healthcare AG
    Inventor: Alex Smolyar
  • Patent number: 7129077
    Abstract: Reagents that regulate human aminopeptidase N and reagents which bind to human aminopeptidase N gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, a CNS disorder or COPD.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: October 31, 2006
    Assignee: Bayer HealthCare AG
    Inventor: Alex Smolyar
  • Publication number: 20050064404
    Abstract: Reagents which regulate human serotonin-like G protein-coupled receptor (5-HT-like GPCR) and reagents which bind to human 5-HT-like GPCR gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, COPD, cardiovascular disorders, cancer, urinary disorders, obesity, diabetes, CNS disorders, asthma, and hematological disorders.
    Type: Application
    Filed: January 21, 2002
    Publication date: March 24, 2005
    Inventor: Alex Smolyar
  • Publication number: 20040241156
    Abstract: Reagents that regulate human aminopeptidase N and reagents which bind to human aminopeptidase N gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, a CNS disorder or COPD.
    Type: Application
    Filed: July 14, 2004
    Publication date: December 2, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040235094
    Abstract: Reagents that regulate human PTPase-like protein and reagents which bind to human PTPase-like protein gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, obesity, diabetes, CNS disorders, cardiovascular disorders or COPD.
    Type: Application
    Filed: June 25, 2004
    Publication date: November 25, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040171539
    Abstract: Reagents that regulate human protein kinase-like protein and reagents which bind to human protein kinase-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, CNS disorders, COPD, obesity, diabetes, and cardiovascular disorders.
    Type: Application
    Filed: April 13, 2004
    Publication date: September 2, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040157222
    Abstract: Reagents which regulate human dendritic cell immunoreceptor and reagents which bind to human dendritic cell immunoreceptor gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, asthma, obesity, diabetes, CNS disorders, and cardiovascular disorders.
    Type: Application
    Filed: July 2, 2003
    Publication date: August 12, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040152092
    Abstract: Reagents that regulate human phosphatidic acid phosphatase type 2C-like protein and reagents which bind to human phosphatidic acid phosphatase type 2C-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, cardiovascular disorders, CNS disorders, COPD, asthma, and diabetes.
    Type: Application
    Filed: October 29, 2003
    Publication date: August 5, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040143092
    Abstract: Reagents which regulate human dorsal root receptor G protein-coupled receptor (dorsal root receptor-like GPCR) and reagents which bind to human dorsal root receptor-like GPCR gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, COPD, cardiovascular disorders, cancer, urinary disorders, obesity, diabetes, peripheral and central nervous system disorders, asthma, and hematological disorders.
    Type: Application
    Filed: January 29, 2004
    Publication date: July 22, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040136976
    Abstract: Reagents that regulate human zinc carboxypeptidase B-like protein and reagents which bind to human zinc carboxypeptidase B-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, CNS disorders, COPD, cardiovascular disorders, urological disorders and hematological disorders.
    Type: Application
    Filed: November 19, 2003
    Publication date: July 15, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040106123
    Abstract: Reagents which regulate human G protein-coupled receptor (GPCR) and reagents which bind to human GPCR gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, COPD, cardiovascular disorders, cancer, urinary disorders, obesity, diabetes, CNS disorders, liver disorders, kidney disorders, disorders of the secretory organs, asthma, a metabolic disease and hematological disorders.
    Type: Application
    Filed: December 8, 2003
    Publication date: June 3, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040101529
    Abstract: Reagents which regulate human serine-threonine protein kinase and reagents which bind to human serine-threonine protein kinase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, CNS disorders, diabetes, asthma, and COPD.
    Type: Application
    Filed: April 14, 2003
    Publication date: May 27, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040076985
    Abstract: Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, HIV infection, cardiovascular disorders, asthma and COPD.
    Type: Application
    Filed: October 27, 2003
    Publication date: April 22, 2004
    Inventors: Alex Smolyar, Zhimin Zhu, Jeffrey Encinas, Shinichi Watanabe, Hiromi Okigami
  • Publication number: 20040048282
    Abstract: Reagents which regulate human Patched-like protein and reagents which bind to human Patched-like protein gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, diabetes, cancer, cardiovascular diseases, and peripheral and central nervous system disorders.
    Type: Application
    Filed: June 4, 2003
    Publication date: March 11, 2004
    Inventor: Alex Smolyar
  • Publication number: 20040030099
    Abstract: Reagents which regulate human Patched-like protein and reagents which bind to human Patched-like protein gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to diabetes, cancer, cardiovascular diseases, and peripheral and central nervous system disorders.
    Type: Application
    Filed: May 5, 2003
    Publication date: February 12, 2004
    Inventor: Alex Smolyar
  • Publication number: 20030059918
    Abstract: Reagents that regulate a novel human serine/threonine protein kinase and reagents which bind to the human serine/threonine protein kinase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cardiovascular disorders, obesity, genitourinary disorders, CNS disorders, diabetes, cancer, and COPD.
    Type: Application
    Filed: June 6, 2002
    Publication date: March 27, 2003
    Applicant: Bayer Aktiengesellschaft
    Inventors: Alex Smolyar, Emma Jane Horner, Craig Thelwell